PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Enterprise Analytics, Jefferson Health.\', \'Division of Pulmonary, Allergy and Critical Care Medicine, Sidney Kimmel College of Medicine; Jane & Leonard Korman Respiratory Institute, Jefferson Health.\', \'Division of Infectious Diseases, Sidney Kimmel College of Medicine.\', \'Department of Neurosurgery; Thomas Jefferson University, Philadelphia, PA, United States.\', \'Enterprise Analytics, Jefferson Health; Jane & Leonard Korman Respiratory Institute, Jefferson Health. Electronic address: jesse.roman@jefferson.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0002-9629(20)30491-210.1016/j.amjms.2020.11.005
?:doi
?:hasPublicationType
?:journal
  • The American journal of the medical sciences
is ?:pmid of
?:pmid
?:pmid
  • 33358502
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Tocilizumab in the Management of COVID-19: A Preliminary Report.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all